Cargando…

Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

Detalles Bibliográficos
Autores principales: Rounis, Konstantinos, Makrakis, Dimitrios, Papadaki, Chara, Monastirioti, Alexia, Vamvakas, Lambros, Kalbakis, Konstantinos, Gourlia, Krystallia, Xanthopoulos, Iordanis, Tsamardinos, Ioannis, Mavroudis, Dimitrios, Agelaki, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635507/
https://www.ncbi.nlm.nih.gov/pubmed/37943834
http://dx.doi.org/10.1371/journal.pone.0294382
_version_ 1785133011118850048
author Rounis, Konstantinos
Makrakis, Dimitrios
Papadaki, Chara
Monastirioti, Alexia
Vamvakas, Lambros
Kalbakis, Konstantinos
Gourlia, Krystallia
Xanthopoulos, Iordanis
Tsamardinos, Ioannis
Mavroudis, Dimitrios
Agelaki, Sofia
author_facet Rounis, Konstantinos
Makrakis, Dimitrios
Papadaki, Chara
Monastirioti, Alexia
Vamvakas, Lambros
Kalbakis, Konstantinos
Gourlia, Krystallia
Xanthopoulos, Iordanis
Tsamardinos, Ioannis
Mavroudis, Dimitrios
Agelaki, Sofia
author_sort Rounis, Konstantinos
collection PubMed
description
format Online
Article
Text
id pubmed-10635507
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-106355072023-11-10 Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study Rounis, Konstantinos Makrakis, Dimitrios Papadaki, Chara Monastirioti, Alexia Vamvakas, Lambros Kalbakis, Konstantinos Gourlia, Krystallia Xanthopoulos, Iordanis Tsamardinos, Ioannis Mavroudis, Dimitrios Agelaki, Sofia PLoS One Correction Public Library of Science 2023-11-09 /pmc/articles/PMC10635507/ /pubmed/37943834 http://dx.doi.org/10.1371/journal.pone.0294382 Text en © 2023 Rounis et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Rounis, Konstantinos
Makrakis, Dimitrios
Papadaki, Chara
Monastirioti, Alexia
Vamvakas, Lambros
Kalbakis, Konstantinos
Gourlia, Krystallia
Xanthopoulos, Iordanis
Tsamardinos, Ioannis
Mavroudis, Dimitrios
Agelaki, Sofia
Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study
title Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study
title_full Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study
title_fullStr Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study
title_full_unstemmed Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study
title_short Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study
title_sort correction: prediction of outcome in patients with non-small cell lung cancer treated with second line pd-1/pdl-1 inhibitors based on clinical parameters: results from a prospective, single institution study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635507/
https://www.ncbi.nlm.nih.gov/pubmed/37943834
http://dx.doi.org/10.1371/journal.pone.0294382
work_keys_str_mv AT rouniskonstantinos correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy
AT makrakisdimitrios correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy
AT papadakichara correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy
AT monastiriotialexia correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy
AT vamvakaslambros correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy
AT kalbakiskonstantinos correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy
AT gourliakrystallia correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy
AT xanthopoulosiordanis correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy
AT tsamardinosioannis correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy
AT mavroudisdimitrios correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy
AT agelakisofia correctionpredictionofoutcomeinpatientswithnonsmallcelllungcancertreatedwithsecondlinepd1pdl1inhibitorsbasedonclinicalparametersresultsfromaprospectivesingleinstitutionstudy